RE:RE:RE:RE:Share Price UP.APHA was harvesting ~5,000kg/qtr (instead of 9,000kg/qtr), based upon investor presentation, due to the mother plants allocation for PIV ramp-up. So the additional 12,000 plants per week (Mar 8 onwards) could yield ~60G/plant (on avg based upon 40-80G/plant) or an additional 720KG/week of full crop rotation, first harvest due this month. So potentially the harvest will double in Q1 2020 to 10,000kg/qtr+ and then triple to10,000kg/month by year-end once achieve full population. Yields expected to continually improve (Mastronardi's), Diamond will be licensed and planting (July??) and ECOE should be online before Oct 17.
Viking49 wrote: Donbgamecock wrote: ediabid wrote: The linked article supports your thinking, Vince. It mentions that once stores opened in Ontario, sales more than doubled. Since that was in April and the last reporting quarter did not include April, we should see improvement in July when they report earnings to May 2019. Hang in guys; the best is yet to come.
Ontario sales doubled when stores began to open
Vinny57 wrote: Why? As I said yesterday, WEED investors jumping ship. The wind has begun to shift. There is MUCH more potential with APHA. The QR WILL be better then the last. A fair bit better (but not nearly as good as the ones that will follow). We are on an UP trend again boys. The ride is just about to begin.
Youre assuming that production will be up. Unless they tap into inventory, i dont see much incease in production for 4QTR19. Their low production last qtr report was based on canibalizing existing production space for staging PIV ramp up. Since PIV didnt open until Feb 19, there is not enough time to capture revenue from March plantings.
Aphria sold 2636 kg during the 3rd quarter fiscal 2019. Aphria does not report the actual harvested during the quarter but even with the reduced through put for clone production I believe the actual harvest is something better than 2636 kg. Inventory value was up 23%, QoQ.
Listening to the 3rd quarter CC, the message was clear that Aphria had packaging constipation and it was a primary area of focus. Improvement in this area will translate to increased revenues. Aphria SKUs appear to have good turnover thru OCS.
I don’t expect the phase 4/5 capacity increase to be captured in the 4th quarter. That product was salable 1st week of June.
Should see increased revenues from CC Pharma as a whole quarter of sales is captured for the 4th quarter versus a partial for 3rd quarter.
Optimistic me says total 4th quarter revenues of $90-$100 million.
Guidance is more in the $80-$90 range.
Fiscal 2020, 1st quarter domestic goals: harvest 2000 kg per week, generate $10 million in revenues per week. That would be my 90 day plan!